Zensar’s strategic acquisition of BridgeView Life Sciences elevates our position as a leading partner for Pharma and Medtech companies, enabling seamless product launches and accelerated commercialization. BridgeView brings unmatched, end-to-end Veeva expertise - spanning advisory, implementation, and managed services - to empower life sciences organizations to achieve success at every stage of their digital journey. Leveraging deep industry insight, proprietary accelerators, and fully integrated solutions across Commercial, Medical, Regulatory, and Quality, we drive measurable business impact and transformative results. We are excited to announce that BridgeView Life Sciences has been recognized as a Major Contender in the Everest Group Veeva Services PEAK Matrix® 2025 assessment - a testament to our relentless focus on innovation, quality, and client success. Together, we are redefining digital transformation in life sciences, empowering organizations to bring groundbreaking therapies to market faster and deliver superior patient outcomes.










